SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-16-125830
Filing Date
2016-09-28
Accepted
2016-09-28 17:30:30
Documents
42
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v449384_10k.htm 10-K 591769
2 EXHIBIT 21 v449384_ex21.htm EX-21 1146
3 EXHIBIT 31.1 v449384_ex31-1.htm EX-31.1 12751
4 EXHIBIT 32.1 v449384_ex32-1.htm EX-32.1 5386
  Complete submission text file 0001144204-16-125830.txt   1854786

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rasp-20160630.xml EX-101.INS 213738
6 XBRL TAXONOMY EXTENSION SCHEMA rasp-20160630.xsd EX-101.SCH 20103
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rasp-20160630_cal.xml EX-101.CAL 12589
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rasp-20160630_def.xml EX-101.DEF 107515
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rasp-20160630_lab.xml EX-101.LAB 113747
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rasp-20160630_pre.xml EX-101.PRE 130534
Mailing Address 420 LEXINGTON AVENUE 25TH FLOOR NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE 25TH FLOOR NEW YORK NY 10170 212-398-4627
Rasna Therapeutics Inc. (Filer) CIK: 0001582249 (see all company filings)

IRS No.: 392080103 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 333-191083 | Film No.: 161907862
SIC: 2834 Pharmaceutical Preparations